Acino is a Swiss pharmaceutical company headquartered in Zurich with a clear focus on selected markets in the Middle East, Africa, the CIS Region, and Latin America. The company is backed by Nordic Capital and Avista Capital Partners.

We deliver quality pharmaceuticals to promote affordable healthcare in these emerging markets and leverage our high-quality pharmaceutical manufacturing capabilities and network to supply leading companies through contract manufacturing and out-licensing.

With a proven track-record and in-depth knowledge of our markets, our dedication to get medication to those who need it most, and with a scientific educational approach, we aim to become the preferred brand for patients and professionals.

When you choose Acino, you are choosing quality you can rely on.